immunotherapies

Research in Review

Immunotherapy Plus Chemotherapy Kills More Cancer Cells Than Chemotherapy Alone

09/09/2016

JCP Editors

When chemotherapy alone is used to treat cancer, some dormant cells may survive and become resistant to additional treatment; but, when combined with immunotherapy, the majority of these cells may be destroyed,...

When...

09/09/2016

Journal of Clinical Pathways

Research in Review

NACT Spurs Immune Response in Patients With Ovarian Cancer

07/08/2016

JCP Editors

Administering immunotherapy immediately after chemotherapy may improve response when treating patients with stage IIIC-IV tubo-ovarian high-grade serous carcinoma, according to findings from a study published in...

...

07/08/2016

Journal of Clinical Pathways

Research in Review

Two Studies Support Immunotherapeutic Agent As First-Line Treatment for NSCLC

07/07/2016

JCP Editors

Nivolumab has demonstrated encouraging activity and acceptable tolerability as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC), according to the results of two phase I,...

...

07/07/2016

Journal of Clinical Pathways

Research in Review

Immunotherapeutic Agents May Cause Arthritis

06/24/2016

JCP Editors

Cancer treatment with the immune checkpoint inhibitors nivolumab and ipilimumab may cause patients to develop inflammatory arthritis or sicca syndrome, claims a study conducted by a group of researchers at Johns...

Cancer...

06/24/2016

Journal of Clinical Pathways